Literature DB >> 11180870

Medial pancreatectomy.

N Rotman1, P L Fagniez.   

Abstract

The surgical treatment of benign tumors of the midportion of the pancreas usually consists of enucleation or formal pancreatectomy. To avoid extended pancreatectomy, a limited resection of the neck of the pancreas has been proposed when enucleation is not feasible. Seven published series report a total number of 78 patients treated by this technique. No postoperative mortality was reported. The operative morbidity ranged from 0% to 40%, mainly due to pancreatic fistulas, which mostly healed spontaneously. In the long term no diabetes mellitus and/or exocrine insufficiency was observed. After resection of low-grade malignant tumors, there was no local recurrence. Medial pancreatectomy is a safe method for the treatment of benign or low-grade malignant tumors of the neck of the pancreas.

Entities:  

Mesh:

Year:  2000        PMID: 11180870     DOI: 10.1007/s005340070014

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  4 in total

1.  Parenchyma-sparing pancreatectomies for benign or border-line tumors of the pancreas.

Authors:  Cosimo Sperti; Valentina Beltrame; Anna Caterina Milanetto; Margherita Moro; Sergio Pedrazzoli
Journal:  World J Gastrointest Oncol       Date:  2010-06-15

2.  Middle segmental pancreatic resection: An option to treat benign pancreatic body lesions.

Authors:  Michael W Müller; Helmut Friess; Jörg Kleeff; Ulf Hinz; Moritz N Wente; Daniel Paramythiotis; Pascal O Berberat; Güralp O Ceyhan; Markus W Büchler
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

Review 3.  [Middle segmental pancreatic resection: an organ-preserving option for benign lesions].

Authors:  M W Müller; V Assfalg; C W Michalski; P Büchler; J Kleeff; H Friess
Journal:  Chirurg       Date:  2009-01       Impact factor: 0.955

4.  Central pancreatectomy for neoplasm of mid pancreas - a report of four cases.

Authors:  Vibha Varma; Vidhyachandra Gandhi; Nagari Bheerappa; Regulagadda Adikesava Sastry
Journal:  Indian J Surg       Date:  2008-11-26       Impact factor: 0.656

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.